Approval · Notice of Compliance 6807 · 2005
EUTHYROX: Notice of Compliance 6807
Issued May 19, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6807
- Date
- May 19, 2005
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product name change from gen-levothyroxine
- Therapeutic class
- Thyroid hormone
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EUTHYROX | 02264323 | Cancelled Post Market |
| EUTHYROX | 02264331 | Cancelled Post Market |
| EUTHYROX | 02264358 | Cancelled Post Market |
| EUTHYROX | 02264366 | Cancelled Post Market |
| EUTHYROX | 02264374 | Cancelled Post Market |
| EUTHYROX | 02264390 | Cancelled Post Market |
| EUTHYROX | 02264404 | Cancelled Post Market |
| EUTHYROX | 02264412 | Cancelled Post Market |
| EUTHYROX | 02264420 | Cancelled Post Market |
| EUTHYROX | 02264439 | Cancelled Post Market |
| EUTHYROX | 02264447 | Cancelled Post Market |
| EUTHYROX | 02264455 | Cancelled Post Market |
Medicinal ingredients
- LEVOTHYROXINE SODIUM 25 MCG per TAB
- LEVOTHYROXINE SODIUM 50 MCG per TAB
- LEVOTHYROXINE SODIUM 75 MCG per TAB
- LEVOTHYROXINE SODIUM 88 MCG per TAB
- LEVOTHYROXINE SODIUM 100 MCG per TAB
- LEVOTHYROXINE SODIUM 112 MCG per TAB
- LEVOTHYROXINE SODIUM 125 MCG per TAB
- LEVOTHYROXINE SODIUM 137 MCG per TAB
- LEVOTHYROXINE SODIUM 150 MCG per TAB
- LEVOTHYROXINE SODIUM 175 MCG per TAB
- LEVOTHYROXINE SODIUM 200 MCG per TAB
- LEVOTHYROXINE SODIUM 300 MCG per TAB